Shopping Cart
- Remove All
- Your shopping cart is currently empty
TL4-12 is a specific MAP4K2/GCK inhibitor that inhibits IKZF1 and BCL-6.TL4-12 inhibits MM cell proliferation and induces apoptosis, and can be used in the study of multiple myeloma (MM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $106 | In Stock | |
5 mg | $213 | In Stock | |
10 mg | $322 | In Stock | |
25 mg | $538 | In Stock | |
50 mg | $768 | In Stock | |
100 mg | $1,050 | In Stock | |
500 mg | $2,080 | In Stock |
Description | TL4-12 is a specific MAP4K2/GCK inhibitor that inhibits IKZF1 and BCL-6.TL4-12 inhibits MM cell proliferation and induces apoptosis, and can be used in the study of multiple myeloma (MM). |
In vitro | The GCK inhibitor TL4-12 downregulates IKZF1 and BCL-6 in a dose-dependent manner, resulting in proliferation inhibition and induction of apoptosis in multiple myeloma cells[1]. |
Alias | TL412, TL4 12 |
Molecular Weight | 500.52 |
Formula | C25H27F3N6O2 |
Cas No. | 1620820-12-3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 5 mg/mL (2.00 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.